Veru VERU
NASDAQ VERU
$2.64 +0.06 (+2.33%)
At close: Aug 21, 2026 · 4:00 PM EDT

Veru (VERU) Change in Accured Expenses (2015 - 2026)

Veru (VERU) posted quarterly Change in Accured Expenses of -$2.3 million for Q1 2026, down 143.88% year-over-year from $5.2 million in Q1 2025, and down 344.12% quarter-over-quarter from $942206.0 in Q4 2025.

Veru (VERU) Change in Accured Expenses (2015 - 2026) Analysis & Trends

Veru (VERU) has reported Change in Accured Expenses for 12 consecutive years, with -$2.3 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Change in Accured Expenses fell 143.88% year-over-year to -$2.3 million; the TTM figure through Mar 2026 stood at -$119017.0 (up 86.4% YoY), while the FY2025 annual figure was -$1.3 million, down 134.16% from the prior year.
  • Change in Accured Expenses retreated to -$2.3 million in Q1 2026 per VERU's latest filing, from $942206.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $8.4 million in Q4 2022 and bottomed at -$9.3 million in Q1 2023.
  • Historically, Change in Accured Expenses has averaged $32207.8 across 5 years, with a median of $530319.0 in 2024.
  • Annual changes were most pronounced in 2022 — Change in Accured Expenses jumped 1356.89% — and 2023, when it slumped 7884.04%.
  • Veru's Change in Accured Expenses stood at $8.4 million in 2022, then plunged by 84.52% to $1.3 million in 2023, then sank by 226.84% to -$1.6 million in 2024, then surged by 157.34% to $942206.0 in 2025, then sank by 344.12% to -$2.3 million in 2026.
  • Business Quant data shows VERU's Change in Accured Expenses at -$2.3 million in Q1 2026, $942206.0 in Q4 2025, and $514877.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 11.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 212.44 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 61.62 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 68.82 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Veru 60.85 Mn 35.06 Mn - 1.03 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.03 Mn
Jun 30, 2026 1.03 Mn
Mar 31, 2026 -2.30 Mn
Mar 31, 2026 -2.30 Mn
Dec 31, 2025 942,206.00
Dec 31, 2025 942,206.00
Sep 30, 2025 514,877.00
Sep 30, 2025 514,877.00
Jun 30, 2025 723,996.00
Jun 30, 2025 723,996.00
Mar 31, 2025 -943,138.00
Mar 31, 2025 -943,138.00
Dec 31, 2024 -1.64 Mn
Dec 31, 2024 -1.64 Mn
Sep 30, 2024 1.18 Mn
Sep 30, 2024 1.18 Mn
Jun 30, 2024 530,319.00
Jun 30, 2024 530,319.00
Mar 31, 2024 937,763.00
Mar 31, 2024 937,763.00